0HAV Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$134.88 |
| 52 Week High | US$151.48 |
| 52 Week Low | US$96.99 |
| Beta | 1.12 |
| 1 Month Change | -8.12% |
| 3 Month Change | 3.82% |
| 1 Year Change | 2.38% |
| 3 Year Change | -2.03% |
| 5 Year Change | 75.82% |
| Change since IPO | 80.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HAV | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -8.6% | -0.9% |
| 1Y | 2.4% | -45.7% | -1.8% |
Return vs Industry: 0HAV exceeded the UK Life Sciences industry which returned -45.7% over the past year.
Return vs Market: 0HAV exceeded the UK Market which returned -1.8% over the past year.
Price Volatility
| 0HAV volatility | |
|---|---|
| 0HAV Average Weekly Movement | 3.1% |
| Life Sciences Industry Average Movement | 7.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HAV has not had significant price volatility in the past 3 months.
Volatility Over Time: 0HAV's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,700 | Mike McMullen | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| 0HAV fundamental statistics | |
|---|---|
| Market cap | US$39.24b |
| Earnings (TTM) | US$1.24b |
| Revenue (TTM) | US$6.74b |
31.8x
P/E Ratio5.8x
P/S RatioIs 0HAV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HAV income statement (TTM) | |
|---|---|
| Revenue | US$6.74b |
| Cost of Revenue | US$3.33b |
| Gross Profit | US$3.41b |
| Other Expenses | US$2.17b |
| Earnings | US$1.24b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.22 |
| Gross Margin | 50.56% |
| Net Profit Margin | 18.35% |
| Debt/Equity Ratio | 41.3% |
How did 0HAV perform over the long term?
See historical performance and comparison